Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,150,488
+$92,771 QoQ
Shares Held
9,589
-28.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 156 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,207,468,471 across 33 Diagnostics & Research names. BLLN ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
813,530 | $184,500,468 | |
| 2 | ICLR |
Icon PLC
|
902,185 | $156,718,555 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
263,413 | $132,064,741 | |
| 4 | DHR |
Danaher Corp /De/
|
489,535 | $93,246,626 | |
| 5 | QGEN |
Qiagen N.V.
|
2,353,350 | $92,015,984 | |
| 6 | LH |
Labcorp Holdings Inc.
|
264,220 | $73,981,600 | |
| 7 | WAT |
Waters Corp /De/
|
185,985 | $69,751,813 | |
| 8 | GH |
Guardant Health, Inc.
|
346,438 | $51,976,092 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,150,488 | 9,589 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,057,717 | 13,399 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||